Related Experiment Video
Updated: Jun 9, 2025
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Effect of an In-Home Palivizumab Administration Program for Children with Medical Complexity
Hina Emanuel1, Aravind Yadav1, Julie C Eapan1
1Department of Pediatrics, Division of Pulmonary Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77030, USA.
Insights
In-home palivizumab (PH) administration significantly reduced healthcare encounters for children with medical complexity (CMC). This home-based approach lowers hospital visits and potential infections for vulnerable pediatric patients.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Healthcare Management
Background:
- In-home palivizumab (PH) administration shows promise for reducing RSV infections.
- PH may benefit children with medical complexity (CMC) by limiting exposure to healthcare-associated infections (HAIs).
Purpose of the Study:
- To evaluate the effectiveness of in-home palivizumab administration compared to clinic-based administration for CMC.
- To assess the impact on healthcare utilization, including face-to-face encounters and hospitalizations.
Main Methods:
- Prospective study of 41 children with CMC (<2 years) randomized to PH or clinic (PC) administration.
- Stratification by home ventilation; primary outcome: total face-to-face encounters; secondary outcomes: unscheduled visits and hospitalizations.
- Standard frequentist and Bayesian analyses were performed.
Main Results:
- The PH group (n=13) showed a significant decrease in total face-to-face encounters (4.5 vs. 8.8) and hospitalizations (0.3 vs. 1.25) compared to the PC group (n=28).
- Bayesian analysis indicated a 93% probability of benefit favoring fewer encounters with PH.
- Demographic factors and strata were well-matched between groups.
Conclusions:
- In-home palivizumab administration appears to reduce healthcare utilization in children with medical complexity.
- Home-based interventions minimizing healthcare facility exposure are promising strategies for CMC.
Background:
In-home palivizumab administration programs (PH) have shown promise in reducing RSV-associated infections. These programs may be particularly beneficial for children with medical complexity (CMC) by limiting their exposure to healthcare-associated infections (HAIs) from non-RSV-related pathogens during transportation and visits to medical facilities.
Methods:
In this prospective study, 41 children with CMC less than 2 years of age were randomized by their health insurance to receive PH or in the clinic (PC) during the RSV season (October 2018-April 2019). Patients were stratified by home ventilation. The primary outcome was the total number of face-to-face encounters. Secondary outcomes were unscheduled clinic visits and hospitalizations secondary to the non-RSV LRTIs. Standard frequentist and Bayesian analyses were performed.
Results:
All demographic factors and strata were matched between PH ("n" = 13, mean age 22 mo. SD ± 1), and PC ("n" = 28, mean age: 18 mo. SD ± 1). There was a decrease in the number of total face-to-face encounters (adjusted for mechanical ventilation and baseline diagnosis) [(4.5 vs. 8.8), (RR: 1.8, 95% CI: 1.3-2.5, p = 0.001)], and hospitalizations [(0.3 vs. 1.25), (RR: 3.8, 95% CI: 1.3-11.3, p = 0.016)], in the PH vs PC groups. Bayesian analysis showed a 93% probability of benefit in favor of fewer face-to-face encounters in the PH group.
Conclusions:
This study suggests that PH administration may reduce healthcare utilization in CMC. Minimizing exposure to healthcare facilities and supporting home-based interventions are promising strategies for this population.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
01:30Asthma-IV: Nursing Management
First, in...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:24Cystic Fibrosis: Management
Sinus disease and chronic...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: